AgelessRx
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, AgelessRx sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
AgelessRx: 7 sponsored US clinical trials, 1 recruiting.
AgelessRx sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. 3 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Longevity, with 2 trials.
Upper-quartile sponsor footprint
AgelessRx sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
NCT07092618
Combination Gerotherapeutic Interventions for Healthspan Improvement
NCT07475546
The Efficacy and Tolerability of Canagliflozin in Healthy Individual
NCT06301529
The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals
NCT06550271
The Efficacy and Tolerability of Acarbose in Healthy Individuals
NCT05542849
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
NCT04604704
Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study
NCT04488601
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the AgelessRx pipeline
1 recruiting of 7 indexed (14% open); 5 completed (71%).
Phase mix: 3 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Longevity (2 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AgelessRx: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
AgelessRx sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
- American College of Radiology · 14% recruiting · 14 trials
Related
What to do with this AgelessRx page
7 registered trials is a research-attention snapshot, not an endorsement of AgelessRx or any single study.
- 1 of AgelessRx's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Longevity is the condition AgelessRx studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Longevity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AgelessRx pipeline card: 7 registered trials from official public datasets.Report a data error.